Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Significant differences were observed between patients with and without sarcopenia regarding sex, smoking status, alcohol consumption, age, BMI, waist circumference, hip circumference, waist-to-hip ratio, serum albumin, uric acid, urea, hemoglobin, 25-hydroxyvitamin D3, TyG index, METS-IR, TyG-BMI, TG/HDL-C, MHR, and SIRI (P < 0.05) (Table 1).
Source: Comparison of baseline characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Development and validation of a predictive model for sarcopenia in patients with type 2 diabetes based on the synergistic mechanism of insulin resistance and inflammation
Study design awaiting verification · Frontiers in Physiology · 2026
Original publication title
Development and validation of a predictive model for sarcopenia in patients with type 2 diabetes based on the synergistic mechanism of insulin resistance and inflammation
Copyright © 2026 Akeaji, Akeaji, Han and Wang.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Type 2 diabetes mellitus (T2DM) complicated by sarcopenia represents a considerable public health challenge, yet early detection remains challenging due to a lack of practical screening tools. The aim of this study was to develop and internally validate a clinically feasible, mechanism-based machine learning model for predicting sarcopenia risk in patients with T2DM.
Source: BackgroundAbstract: What methods does the paper describe?
A total of 904 patients with T2DM treated at the First Affiliated Hospital of Xinjiang Medical University from May 2024 to May 2026 were retrospectively enrolled. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia (AWGS) 2025 consensus. The dataset was randomly partitioned into training (70%) and internal validation (30%) sets. Key predictive features were identified by intersecting the variables selected via least absolute shrinkage and selection operator (LASSO) regression and the Boruta algorithm. Eight machine learning algorithms were subsequently developed and evaluated.
Source: MethodsAbstract: Results
The prevalence of sarcopenia among the patients with T2DM was 29.20%. Eight predictors were selected: age, sex, body mass index, serum albumin, alanine aminotransferase, hemoglobin, metabolic score for insulin resistance, and monocyte-to-high-density lipoprotein cholesterol ratio. LightGBM demonstrated the best overall predictive performance in the validation set, yielding an area under the receiver operating characteristic curve (AUC) of 0.928, an accuracy of 0.882, a sensitivity of 0.897, a specificity of 0.876, a precision of 0.745, and an F1 score of 0.814.
Calibration and decision curve analysis indicated that the model yielded clinical net benefit. A web-based calculator developed using LightGBM enabled three-tier risk stratification: low (<15%), moderate (15%: 40%), and high (>40%).
Source: ResultsAbstract: Conclusion
A machine learning model for predicting sarcopenia risk in patients with T2DM was developed and internally validated, resulting in the implementation of an online risk calculator. This mechanism-based model demonstrated promising internal predictive performance and may provide a practical and cost-effective screening approach for diabetes management.
Source: ConclusionAuthors’ abstract
Background
Type 2 diabetes mellitus (T2DM) complicated by sarcopenia represents a considerable public health challenge, yet early detection remains challenging due to a lack of practical screening tools. The aim of this study was to develop and internally validate a clinically feasible, mechanism-based machine learning model for predicting sarcopenia risk in patients with T2DM.
Methods
A total of 904 patients with T2DM treated at the First Affiliated Hospital of Xinjiang Medical University from May 2024 to May 2026 were retrospectively enrolled. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia (AWGS) 2025 consensus. The dataset was randomly partitioned into training (70%) and internal validation (30%) sets. Key predictive features were identified by intersecting the variables selected via least absolute shrinkage and selection operator (LASSO) regression and the Boruta algorithm. Eight machine learning algorithms were subsequently developed and evaluated.
Results
The prevalence of sarcopenia among the patients with T2DM was 29.20%. Eight predictors were selected: age, sex, body mass index, serum albumin, alanine aminotransferase, hemoglobin, metabolic score for insulin resistance, and monocyte-to-high-density lipoprotein cholesterol ratio. LightGBM demonstrated the best overall predictive performance in the validation set, yielding an area under the receiver operating characteristic curve (AUC) of 0.928, an accuracy of 0.882, a sensitivity of 0.897, a specificity of 0.876, a precision of 0.745, and an F1 score of 0.814.
Calibration and decision curve analysis indicated that the model yielded clinical net benefit. A web-based calculator developed using LightGBM enabled three-tier risk stratification: low (<15%), moderate (15%: 40%), and high (>40%).
Conclusion
A machine learning model for predicting sarcopenia risk in patients with T2DM was developed and internally validated, resulting in the implementation of an online risk calculator. This mechanism-based model demonstrated promising internal predictive performance and may provide a practical and cost-effective screening approach for diabetes management.
Publication and source details
Original title: Development and validation of a predictive model for sarcopenia in patients with type 2 diabetes based on the synergistic mechanism of insulin resistance and inflammation
Ajinisha Akeaji; Baihetinisha Akeaji; Yihe Han; Ning Wang
Frontiers in Physiology · 2026
* Correspondence: Ning Wang, 13999994126@163.comCopyright © 2026 Akeaji, Akeaji, Han and Wang.2026Akeaji, Akeaji, Han and Wanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This project was supported by the Tianshan Talents Medical and Health High-Level Personnel Training Program of Xinjiang Uygur Autonomous Region (TSYC202401A039).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:34:31.314685+00:00
DOI: 10.3389/fphys.2026.1922889 · PMC13634868